These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12725947)

  • 21. Platelet utilization in the developing world: strategies to optimize platelet transfusion practices.
    Verma A; Agarwal P
    Transfus Apher Sci; 2009 Oct; 41(2):145-9. PubMed ID: 19716339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet transfusion for patients with platelet dysfunction: effectiveness, mechanisms, and unanswered questions.
    Lee RH; Kasthuri RS; Bergmeier W
    Curr Opin Hematol; 2020 Nov; 27(6):378-385. PubMed ID: 32868672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet transfusion therapy.
    AuBuchon JP
    Clin Lab Med; 1996 Dec; 16(4):797-816. PubMed ID: 8974196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A critical comparison of platelet preparation methods.
    Vassallo RR; Murphy S
    Curr Opin Hematol; 2006 Sep; 13(5):323-30. PubMed ID: 16888436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating thrombocytopenia with pathogen-reduced platelets.
    Sandler SG
    Curr Hematol Rep; 2006 Mar; 5(1):53-4. PubMed ID: 16537046
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
    Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
    Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic efficacy of pooled buffy-coat platelet components prepared and stored with a platelet additive solution.
    van Rhenen DJ; Gulliksson H; Cazenave JP; Pamphilon D; Davis K; Flament J; Corash L
    Transfus Med; 2004 Aug; 14(4):289-95. PubMed ID: 15285725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lower or higher doses for prophylactic platelet transfusions: results of a meta-analysis of randomized controlled trials.
    Cid J; Lozano M
    Transfusion; 2007 Mar; 47(3):464-70. PubMed ID: 17319827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfusion support to Dengue patients in a hospital based blood transfusion service in north India.
    Chaudhary R; Khetan D; Sinha S; Sinha P; Sonker A; Pandey P; Das SS; Agarwal P; Ray V
    Transfus Apher Sci; 2006 Dec; 35(3):239-44. PubMed ID: 17097349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of high-yield thrombocytapheresis on the quality of platelet products.
    Julmy F; Ammann RA; Mansouri Taleghani B; Fontana S; Hirt A; Leibundgut K
    Transfusion; 2008 Mar; 48(3):442-50. PubMed ID: 18067508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of efficacy of prophylactic platelet transfusion for severe thrombocytopenia in adults with acute uncomplicated dengue infection.
    Lye DC; Lee VJ; Sun Y; Leo YS
    Clin Infect Dis; 2009 May; 48(9):1262-5. PubMed ID: 19292665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?
    Stanworth SJ; Hyde C; Brunskill S; Murphy MF
    Br J Haematol; 2005 Dec; 131(5):588-95. PubMed ID: 16351634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of platelet transfusions evaluated using rotational thromboelastometry.
    Flisberg P; Rundgren M; Engström M
    Anesth Analg; 2009 May; 108(5):1430-2. PubMed ID: 19372316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet utilization and the transfusion trigger: a prospective analysis.
    Greeno E; McCullough J; Weisdorf D
    Transfusion; 2007 Feb; 47(2):201-5. PubMed ID: 17302764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light.
    Murphy S; Snyder E; Cable R; Slichter SJ; Strauss RG; McCullough J; Lin JS; Corash L; Conlan MG;
    Transfusion; 2006 Jan; 46(1):24-33. PubMed ID: 16398727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of patients refractory to platelet transfusion.
    Chockalingam P; Sacher RA
    J Infus Nurs; 2007; 30(4):220-5. PubMed ID: 17667077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of random versus apheresis platelet concentrates.
    Andreu G; Vasse J; Sandid I; Tardivel R; Semana G
    Transfus Clin Biol; 2007 Dec; 14(6):514-21. PubMed ID: 18417401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).
    Tosetto A; Balduini CL; Cattaneo M; De Candia E; Mariani G; Molinari AC; Rossi E; Siragusa S;
    Thromb Res; 2009 Nov; 124(5):e13-8. PubMed ID: 19631969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of crossmatch tests and panel tests as a screening tool to predict the outcome of platelet transfusion in a non-selected haematological population of patients.
    Levin MD; van der Holt B; de Veld JC; Gratama JW; de Vries W; van't Veer MB
    Vox Sang; 2004 Nov; 87(4):291-8. PubMed ID: 15585026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombocytopenia in hydropic fetuses with parvovirus B19 infection: incidence, treatment and correlation with fetal B19 viral load.
    de Haan TR; van den Akker ES; Porcelijn L; Oepkes D; Kroes AC; Walther FJ
    BJOG; 2008 Jan; 115(1):76-81. PubMed ID: 18053103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.